AcSDKP增强老年大鼠卒中后tPA溶栓疗效
研究在18月龄雄性大鼠栓塞性大脑中动脉闭塞模型中,比较AcSDKP、tPA、两药联用与生理盐水。联用组显著减少梗死体积、改善神经功能且不增加脑出血,并增强微血管灌注、减少血栓形成和血脑屏障渗漏。
要点
- AcSDKP或tPA单药治疗在老年卒中大鼠中无显著疗效。
- AcSDKP联合tPA减少梗死、改善神经功能且不增加出血。
- 联用机制可能涉及增强脑内皮细胞屏障完整性。
核心结论
- AcSDKP联合tPA在卒中后4小时对老年大鼠栓塞性卒中有治疗疗效。
研究设计与样本
- 18月龄雄性大鼠行栓塞性大脑中动脉闭塞,4小时后随机分为AcSDKP组、tPA组、联用组和生理盐水组。
- 在闭塞后1天和7天评估神经功能缺损、脑微血管通畅性与完整性及梗死。
- 体外实验检测AcSDKP对老年脑内皮细胞通透性的影响。
主要发现
- 与生理盐水相比,AcSDKP或tPA单药治疗均无任何治疗效应。
- AcSDKP联合tPA显著减少脑组织梗死并改善神经功能结局,且不增加脑出血。
- 联用治疗显著增强微血管灌注并减少血栓形成和血脑屏障渗漏。
- 体外实验中,缺血老年大鼠脑内皮细胞渗漏显著高于缺血成年大鼠。
- AcSDKP抑制tPA诱导的老年内皮细胞渗漏并降低ICAM-1和NF-κB表达。
临床怎么用
- 在老年栓塞性卒中模型中,AcSDKP可能通过作用于脑内皮细胞增强tPA获益。
- 联用策略可能提高组织灌注并增强血脑屏障完整性。
局限性
- 研究为老年雄性大鼠临床前实验,结论需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Stroke is a leading cause of disability worldwide, mainly affecting the elderly. However, preclinical studies in aged ischemic animals are limited. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a naturally occurring tetrapeptide with vascular-protective properties. The present study investigated the effect of AcSDKP on tPA (tissue-type plasminogen activator)-induced thrombolysis in aged rats after ischemic stroke. Methods- Aged male rats (18 months) were subjected to embolic middle cerebral artery occlusion. Rats subjected to 4 hours of middle cerebral artery occlusion were randomized into the following groups: (1) AcSDKP; (2) tPA; (3) AcSDKP in combination with tPA; and (4) saline. Neurological deficits, cerebral microvascular patency and integrity, and infarction were examined at 1 day and 7 days after middle cerebral artery occlusion. In vitro experiments were performed to examine the effect of AcSDKP on aged cerebral endothelial cell permeability. Results- Compared with saline, AcSDKP, or tPA as monotherapy did not have any therapeutic effects, whereas AcSDKP in combination with tPA significantly reduced cerebral tissue infarction and improved neurological outcome without increasing cerebral hemorrhage. Concurrently, the combination treatment significantly augmented microvascular perfusion and reduced thrombosis and blood-brain barrier leakage. In vitro, compared with cerebral endothelial cells from ischemic adult rats, the endothelial cells from ischemic aged rats exhibited significantly increased leakage. AcSDKP suppressed tPA-induced aged endothelial cell leakage and reduced expression of ICAM-1 (intercellular adhesion molecule 1) and NF (nuclear factor)-κB. Conclusions- The present study provides evidence for the therapeutic efficacy of AcSDKP in combination tPA for the treatment of embolic stroke in aged rats at 4 hours after stroke onset. AcSDKP likely acts on cerebral endothelial cells to enhance the benefits of tPA by increasing tissue perfusion and augmenting the integrity of the blood-brain barrier. Visual Overview- An online visual overview is available for this article.
引用
- Li C, Zhang L, Wang C, et al. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke. Stroke. 2019. PMID: 31387512. doi:10.1161/STROKEAHA.119.026212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。